Thursday, 08. January 2009

Startpage > All projects > FP6 Life Science Health > Advanced genomics and its applications for health > Application of knowledge and technologies > Development and testing of new preventive and therapeutic tools > Oncolytic virus vectors for cancer virotherapy (especially orientated towards involvement of SMEs)


		All projects


		FP6 Life Science Health


		Advanced genomics and its applications for health


		Fundamental knowledge and basic tools for functional genomics


		Application of knowledge and technologies


		Rational and accelerated development of new, safer, more effective drugs


		Development of new diagnostics


		Development and testing of new preventive and therapeutic tools


		New advances in cell based therapies for the regeneration of connective tissue


		New improved vaccines based on genomic and proteomic information


		Oncolytic virus vectors for cancer virotherapy (especially orientated towards involvement of SMEs)


		Tissue engineering approaches to treating children with birth defects


		Use of baculovirus as a vector in gene therapy (especially orientated towards small and medium sized companies)


		Combating major diseases


		Specific support actions across thematic priority 1


		FP6 Information society technologies


		FP6 Others


		FP5 Life Quality


		About the region


		Thematic areas


		IFR


		About European projects

Jean-Jacques DIAZ (»add to infobox)

Contact at
NUCLEALP (FR718 - Haute-Savoie)

WORKED WITH (2/2)

Andres CRESPO (Contact / GENOPOIETIC SAS (FR711 - Ain) (France))

Alberto EPSTEIN (Contact / UNIVERSITE CLAUDE BERNARD LYON 1 (FR716 - Rhône) (France))

RELATED PROJECTS (1/1)

THOVLEN - Targeted Herpesvirus-derived Oncolytic Vectors for Liver cancer European Network (FP6-LIFESCIHEALTH)

SEARCH

Advanced Search

OVERVIEWS

Sitemap

Organisation List

Person List

INFOBOX (0/0)

show all


Your infobox is empty

Powered by AVERIS